AVR
Anteris Technologies Global Corp.Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation tha
2-Year Price History
Quarterly Financials & Projections
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.5 | -23.6 | -24.0 | -23.0 | -28.7 | -28.8 | -0.1 | 283.2 | 3.7 | 23.6 | -34.0% | -873.3x | -- |
| Act | 2025-Q4 | 0.3 | -28.5 | -29.0 | -29.2 | -18.5 | -18.8 | -0.3 | 12.6 | 2.3 | 23.6 | <-999% | -2854.2x | -- |
Valuation & Metrics
Market Stats
TTM Financial Snapshot
Forward Outlook & Risk
Short Interest
Employees
Institutional Ownership
Headline & net flow
Ownership composition
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| L1 Capital Pty Ltd | $43.2M | $4.80 | +$27.6M | +$5.0M | +2.5% | $2.55B |
| Nantahala Capital Management, LLC | $30.7M | $5.44 | +$16.7M | +$21.5M | -2.4% | $1.60B |
| Sio Capital Management, LLC | $29.9M | $5.55 | +$19.5M | +$16.7M | -1.1% | $694M |
| BlackRock, Inc.Passive | $27.1M | $4.97 | +$15.9M | +$24.9M | -0.2% | $5.69T |
| ADAR1 Capital Management, LLC | $21.0M | $5.22 | +$14.2M | +$11.7M | +8.4% | $1.64B |
| PERCEPTIVE ADVISORS LLC | $19.0M | $5.57 | +$9.7M | +$7.1M | -1.4% | $5.05B |
| RA CAPITAL MANAGEMENT, L.P. | $16.7M | $5.55 | +$16.7M | +$16.7M | -4.4% | $9.44B |
| BVF INC/IL | $16.7M | $5.55 | +$16.7M | +$16.7M | -0.4% | $3.14B |
| FMR LLC | $16.1M | $5.54 | +$15.9M | +$16.1M | -0.0% | $1.89T |
| Ensign Peak Advisors, Inc | $11.6M | $5.20 | +$3.8M | +$3.6M | -0.4% | $53.58B |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $10.2M | $4.93 | +$5.8M | +$9.3M | +2.3% | $1.61T |
| Rhenman & Partners Asset Management AB | $8.0M | $3.90 | +$1.1M | +$825K | -1.1% | $784M |
| UBS Group AG | $7.8M | $5.07 | +$4.9M | +$7.1M | -0.3% | $562.11B |
| STATE STREET CORPPassive | $6.8M | $5.14 | +$4.8M | +$6.3M | -0.2% | $2.89T |
| Vestal Point Capital, LP | $6.4M | $5.55 | +$6.4M | +$6.4M | -0.1% | $3.58B |
| Affinity Asset Advisors, LLC | $5.1M | $5.25 | +$2.4M | +$2.9M | +0.5% | $1.60B |
| Oasis Management Co Ltd. | $4.8M | $5.56 | +$4.4M | +$4.0M | -3.1% | $729M |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $4.8M | $5.55 | +$4.8M | +$4.8M | — | $4.04T |
| SUVRETTA CAPITAL MANAGEMENT, LLC | $4.7M | $5.55 | +$4.7M | +$4.7M | -9.1% | $3.69B |
| Alyeska Investment Group, L.P. | $4.2M | $5.57 | +$1.1M | +$1.1M | -0.5% | $35.33B |
Trading behavior
▸ Compare to holder-profile behavior (across all their stocks)
Biggest decreases this quarter
New buyers this quarter
Top-5 holders · 42.7%
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
Related Stocks
Investors who own this also own
Stocks held by the same active managers as this one, ranked by score — how much more often these appear together than random chance (1× = baseline). Excludes index ETFs and market makers; minimum 3 shared holders.
| Ticker | Name | Co-holders | Score |
|---|---|---|---|
| ABVX | Abivax S.A. | 3 | 77.71× |
Analyst Coverage
Corporate
Insider Trading (last 12mo)
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2026-01-22 | BUY | L1 Capital Pty Ltd | 10 percent owner | 5,000,000 | $5.75 | $28.75M | $76.01M |
| 2025-10-28 | BUY | L1 Capital Pty Ltd | 10 percent owner | 1,333,334 | $0.00 | $0 | $0 |
Order Flow (FINRA, ~3w lag)
Filing Risk Analysis
Filing Risk Scores
Anteris Technologies: Massive Post-Period Dilution Masks Year-End Technical Insolvency